Concepedia

Srinivas Bachina

SB

Statistics

Publications

2

Citations

126

H-Index

2

Active since

2018

Affiliations

Clinical Research Institute(Current)

University of Groningen

University Medical Center Groningen

Duke University

AstraZeneca (United States)

Srinivas Bachina is an author at Clinical Research Institute specializing in pharmacology, cardiovascular pharmacotherapy, and pharmacotherapy.

Publications per year

2018–2019

2

Publications

2

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Lindsay E. Clegg, Robert C. Penland, Srinivas Bachina et al. · Cardiovascular Diabetology · 2019 · 94 citations · Full text

, , +17

Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL

Lindsay E. Clegg, Hiddo J.L. Heerspink, Robert C. Penland et al. · Diabetes Care · 2018 · 32 citations · Full text

, , +17

1–2 of 2